Hiroko Okinaga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hiroko Okinaga has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Masanao Kurata
Department of Hepatobiliary-Pancreatic Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
1 shared publication - Mei Nakamura
Department of Hepatobiliary-Pancreatic Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
1 shared publication - Nobuyuki Takemura
Department of Hepato-Biliary-Pancreatic Surgery and Pediatric Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan
1 shared publication - Riki Ninomiya
Department of Hepato-Biliary-Pancreatic Surgery and Pediatric Surgery, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan
1 shared publication - Tomoaki Sawano
Department of Hepatobiliary-Pancreatic Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
1 shared publication - Yasuji Seyama
Department of Hepatobiliary-Pancreatic Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 14 October 2026
- Published by Springer Nature in Langenbeck's Archives of Surgery
Sensor-assisted firing execution (SAFE) cut: a quantitatively standardized technique for pancreatic transection in robotic distal pancreatectomy
Purpose: In robotic distal pancreatectomy (RDP), the lack of haptic feedback and delegation of stapler firing to the bedside assistant make compression quality during transection highly operator-dependent. We describe the “SAFE Cut” (Sensor-Assisted Firing Execution) technique, a quantitatively standardized protocol that converts the subjective “wait-and-fire” judgment into an objective, device-guided workflow. Methods: A smart stapler displays tissue resistance as nine stratifications across three color-coded Zones (1–1 to 3–3). A mandatory pre-firing wait (immediate to 60 s) was assigned to each segment and re-applied at every incremental firing step. We reviewed 31 consecutive patients undergoing RDP with the SAFE Cut technique, analyzing prospectively recorded Zone observations for all firing steps. Results: The protocol was completed without protocol-related conversion, repositioning, or technical failure in all 31 patients (31 of 31); in every case the stapler was operated by a bedside trainee. Median transection time was 13.3 min (8.7–23.0). CR-POPF occurred in 1 patient (3.2%), with no Grade C fistula and no 90-day mortality. Across 1,179 firing steps, Zone 1 occurred in 940 (79.7%) and Zone 2 in 239 (20.3%); Zone 3 never occurred. Because each step advances the stapler to new tissue, consecutive readings sample different segments; the step after a Zone 2 reading displayed Zone 1 in 136 of 239 events (56.9%). Conclusion: The SAFE Cut technique is feasible: the Zone-guided protocol was completed in every patient by a bedside trainee, making the previously hidden heterogeneity of tissue resistance quantifiable. This study was not designed to test fistula prevention; the CR-POPF rate was low, but a study of this size cannot establish efficacy, and whether the approach reduces fistula, and whether comparably low rates recur in other cohorts, needs prospective study.
- 14 October 2026
- Published by Springer Nature in Langenbeck's Archives of Surgery
Open AccessSensor-assisted firing execution (SAFE) cut: a quantitatively standardized technique for pancreatic transection in robotic distal pancreatectomy
Purpose: In robotic distal pancreatectomy (RDP), the lack of haptic feedback and delegation of stapler firing to the bedside assistant make compression quality during transection highly operator-dependent. We describe the “SAFE Cut” (Sensor-Assisted Firing Execution) technique, a quantitatively standardized protocol that converts the subjective “wait-and-fire” judgment into an objective, device-guided workflow. Methods: A smart stapler displays tissue resistance as nine stratifications across three color-coded Zones (1–1 to 3–3). A mandatory pre-firing wait (immediate to 60 s) was assigned to each segment and re-applied at every incremental firing step. We reviewed 31 consecutive patients undergoing RDP with the SAFE Cut technique, analyzing prospectively recorded Zone observations for all firing steps. Results: The protocol was completed without protocol-related conversion, repositioning, or technical failure in all 31 patients (31 of 31); in every case the stapler was operated by a bedside trainee. Median transection time was 13.3 min (8.7–23.0). CR-POPF occurred in 1 patient (3.2%), with no Grade C fistula and no 90-day mortality. Across 1,179 firing steps, Zone 1 occurred in 940 (79.7%) and Zone 2 in 239 (20.3%); Zone 3 never occurred. Because each step advances the stapler to new tissue, consecutive readings sample different segments; the step after a Zone 2 reading displayed Zone 1 in 136 of 239 events (56.9%). Conclusion: The SAFE Cut technique is feasible: the Zone-guided protocol was completed in every patient by a bedside trainee, making the previously hidden heterogeneity of tissue resistance quantifiable. This study was not designed to test fistula prevention; the CR-POPF rate was low, but a study of this size cannot establish efficacy, and whether the approach reduces fistula, and whether comparably low rates recur in other cohorts, needs prospective study.